ATRASENTAN

ATRASENTAN was reported 101 times

ATRASENTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLATELET-LARGE CELL RATIO DECREASED 1 0.1429
1 PLATELET DISTRIBUTION WIDTH DECREASED 1 0.0213
2 PLATELETCRIT DECREASED 1 0.0133
3 CREATININE URINE DECREASED 1 0.0063
4 CALCIUM METABOLISM DISORDER 1 0.0053
5 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
6 CERVICOBRACHIAL SYNDROME 1 0.0016
7 PROTEIN TOTAL ABNORMAL 2 0.0015
8 IGA NEPHROPATHY 2 0.0012
9 PROTEIN URINE 1 0.0011
10 BONE GRAFT 1 0.0011
11 TUMOUR NECROSIS 1 0.0009
12 CARBON DIOXIDE DECREASED 1 0.0009
13 HYPERAESTHESIA TEETH 1 0.0008
14 GLUCOSE URINE PRESENT 1 0.0008
15 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
16 FOOD AVERSION 1 0.0006
17 SKIN WOUND 1 0.0006
18 BLOOD IRON INCREASED 1 0.0005
19 ORAL INTAKE REDUCED 1 0.0004
20 HYPERVOLAEMIA 2 0.0004
21 LACTOSE INTOLERANCE 1 0.0004
22 PROTEIN TOTAL INCREASED 1 0.0004
23 BLOOD POTASSIUM ABNORMAL 1 0.0004
24 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
25 PROTEIN TOTAL DECREASED 1 0.0003
26 HYPOALBUMINAEMIA 2 0.0003
27 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
28 HORDEOLUM 1 0.0002
29 BLOOD CREATINE INCREASED 1 0.0002
30 PROTEINURIA 4 0.0002
31 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
32 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
33 BLOOD POTASSIUM INCREASED 3 0.0002
34 PERIORBITAL SWELLING 1 0.0002
35 HYPERCHLORHYDRIA 1 0.0002
36 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
37 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
38 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
39 FEAR OF INJECTION 1 0.0001
40 INTENTIONAL UNDERDOSE 1 0.0001
41 CONCUSSION 1 0.0001
42 PULMONARY HAEMORRHAGE 1 0.0001
43 RHINITIS 1 0.0001
44 BLOOD CALCIUM INCREASED 1 0.0001
45 SPINAL OSTEOARTHRITIS 1 0.0001
46 FLANK PAIN 1 0.0001
47 INCREASED APPETITE 2 0.0001
48 LABORATORY TEST ABNORMAL 3 0.0001
49 OEDEMA 5 0.0001
50 HYPERTENSIVE CRISIS 1 0.0001
51 BLOOD CALCIUM DECREASED 1 0.0001
52 VASCULITIS 1 0.0001
53 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
54 FLUID RETENTION 4 0.0001
55 BLOOD CREATININE INCREASED 5 0.0001
56 MENSTRUATION IRREGULAR 2 0.0001
57 LYMPHOPENIA 1 0.0001
58 ANOSMIA 1 0.0001
59 SKIN DISCOLOURATION 3 0.0001
60 SWELLING 6 0.0001
61 BLOOD UREA INCREASED 1 0.0001
62 RENAL IMPAIRMENT 5 0.0001
63 FACE OEDEMA 1 0.0001
64 HAEMATURIA 2 0.0001
65 ORTHOSTATIC HYPOTENSION 1 0.0001
66 END STAGE RENAL DISEASE 1 0.0001
67 BLOOD SODIUM DECREASED 1 0.0001
68 BLOOD URINE PRESENT 1 0.0001
69 SINUS DISORDER 1 0.0001
70 HAEMATOCRIT DECREASED 1 0.0001
71 BLOOD PRESSURE ABNORMAL 1 0.0001
72 PRESCRIBED UNDERDOSE 1 0.0001
73 PRODUCT ADMINISTRATION ERROR 1 0.0000
74 EATING DISORDER 1 0.0000
75 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
76 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
77 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
78 PRODUCT PRESCRIBING ERROR 1 0.0000
79 AGEUSIA 1 0.0000
80 LEUKOPENIA 2 0.0000
81 PERIPHERAL SWELLING 6 0.0000
82 MUCOSAL INFLAMMATION 1 0.0000
83 BLOOD BILIRUBIN INCREASED 1 0.0000
84 SKIN LESION 1 0.0000
85 HYPONATRAEMIA 2 0.0000
86 RED BLOOD CELL COUNT DECREASED 1 0.0000
87 ACUTE MYOCARDIAL INFARCTION 1 0.0000
88 URINARY INCONTINENCE 1 0.0000
89 BLOOD POTASSIUM DECREASED 1 0.0000
90 LACRIMATION INCREASED 1 0.0000
91 OEDEMA PERIPHERAL 4 0.0000
92 VERTIGO 2 0.0000
93 SWELLING FACE 2 0.0000
94 EYE PRURITUS 1 0.0000
95 PANIC ATTACK 1 0.0000
96 EYE SWELLING 1 0.0000
97 DISORIENTATION 1 0.0000
98 VAGINAL HAEMORRHAGE 1 0.0000
99 TINNITUS 1 0.0000
100 HYPOKALAEMIA 1 0.0000
101 RENAL DISORDER 1 0.0000
102 ARRHYTHMIA 1 0.0000
103 ANAEMIA 4 0.0000
104 RASH ERYTHEMATOUS 1 0.0000
105 LUNG DISORDER 1 0.0000
106 PRODUCT DOSE OMISSION ISSUE 6 0.0000
107 DYSPEPSIA 2 0.0000
108 SINUSITIS 2 0.0000
109 ABDOMINAL DISTENSION 2 0.0000
110 NERVOUSNESS 1 0.0000
111 DEPRESSED MOOD 1 0.0000
112 INFLUENZA 2 0.0000
113 OXYGEN SATURATION DECREASED 1 0.0000
114 CATARACT 1 0.0000
115 DISCOMFORT 1 0.0000
116 FEELING HOT 1 0.0000
117 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
118 DEVICE DIFFICULT TO USE 1 0.0000
119 NEOPLASM MALIGNANT 1 0.0000
120 CONSTIPATION 3 0.0000
121 WEIGHT INCREASED 3 0.0000
122 ACNE 1 0.0000
123 BLOOD PRESSURE INCREASED 2 0.0000
124 DECREASED APPETITE 3 0.0000
125 INJECTION SITE BRUISING 1 0.0000
126 CARDIAC FAILURE 1 0.0000
127 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
128 DIZZINESS 6 0.0000
129 ABDOMINAL DISCOMFORT 2 0.0000
130 PYREXIA 4 0.0000
131 FATIGUE 9 0.0000
132 RASH 5 0.0000
133 COVID-19 2 0.0000
134 NASOPHARYNGITIS 2 0.0000
135 HYPERSENSITIVITY 2 0.0000
136 PULMONARY EMBOLISM 1 0.0000
137 MIGRAINE 1 0.0000
138 DRUG INTOLERANCE 1 0.0000
139 HEART RATE INCREASED 1 0.0000
140 HYPOTENSION 2 0.0000
141 SOMNOLENCE 2 0.0000
142 FLUSHING 1 0.0000
143 HAEMOGLOBIN DECREASED 1 0.0000
144 ERYTHEMA 2 0.0000
145 ABDOMINAL PAIN UPPER 2 0.0000
146 HYPERTENSION 2 0.0000
147 PLATELET COUNT DECREASED 1 0.0000
148 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
149 THROMBOCYTOPENIA 1 0.0000
150 DISEASE PROGRESSION 1 0.0000
151 JOINT SWELLING 1 0.0000
152 NAUSEA 6 0.0000
153 RENAL FAILURE 1 0.0000
154 NEUTROPENIA 1 0.0000
155 VISION BLURRED 1 0.0000
156 DRUG INEFFECTIVE 9 0.0000
157 HYPOAESTHESIA 1 0.0000
158 CONDITION AGGRAVATED 2 0.0000
159 ACUTE KIDNEY INJURY 1 0.0000
160 HOSPITALISATION 1 0.0000
161 VOMITING 3 0.0000
162 DRUG INTERACTION 1 0.0000
163 CONFUSIONAL STATE 1 0.0000
164 PNEUMONIA 2 0.0000
165 TREMOR 1 0.0000
166 URINARY TRACT INFECTION 1 0.0000
167 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
168 BLOOD GLUCOSE INCREASED 1 0.0000
169 GAIT DISTURBANCE 1 0.0000
170 PRURITUS 2 0.0000
171 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
172 HEADACHE 3 0.0000
173 INCORRECT DOSE ADMINISTERED 1 0.0000
174 ABDOMINAL PAIN 1 0.0000
175 WEIGHT DECREASED 1 0.0000
176 COUGH 1 0.0000
177 OFF LABEL USE 3 0.0000
178 PAIN IN EXTREMITY 1 0.0000
179 ASTHENIA 1 0.0000
180 ARTHRALGIA 1 0.0000
181 MALAISE 1 0.0000
182 DYSPNOEA 1 0.0000
183 PAIN 1 0.0000
184 DIARRHOEA 1 0.0000